2026-2034年全球迷幻蘑菇市场规模、份额、趋势和成长分析报告

预计到 2034 年，致幻蘑菇市场规模将从 2025 年的 18.7 亿美元成长至 47.2 亿美元，2026 年至 2034 年的复合年增长率为 10.81%。

随着对致幻物质治疗潜力的研究不断深入，全球致幻蘑菇市场日益受到关注。含有裸盖菇素等化合物的迷幻蘑菇正被研究用于治疗忧郁症、焦虑症和创伤后压力症候群（PTSD）等精神疾病。人们对替代精神疗法的兴趣日益浓厚，也推动了该领域的研究和投资不断增加。

多地监管政策的变化也影响市场发展。一些国家和地区正在重新审视迷幻物质用于医学研究和治疗的法律限制。这项变化促使製药公司和研究机构探索基于裸盖菇素治疗方法的医学应用。此外，临床试验也为迷幻剂辅助疗法的潜在益处提供了新的见解。

展望未来，随着科学研究不断证实其治疗应用价值，全球迷幻蘑菇市场预计将持续发展。各公司正在探索药用级裸盖菇素製剂以及针对精神疾病的受控治疗方案。随着人们对精神健康问题的认识不断提高以及研究的深入，基于迷幻蘑菇的治疗方法市场有望逐步扩大。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球迷幻蘑菇市场：依形态划分

• 市场分析、洞察与预测
• 按处理类型
• 干粉
• 新鲜/完整形式

第五章：全球迷幻蘑菇市场：功能性

• 市场分析、洞察与预测
• 戒除成瘾
• 缓解焦虑
• 忧郁症的治疗
• 用于休閒目的

第六章：全球迷幻蘑菇市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • MindMed
  • Atai Life Sciences
  • Compass Pathways
  • Field Trip Health
  • Cybin Inc
  • Revive Therapeutics
  • Numinus Wellness
  • Seelos Therapeutics
  • GH Research
  • Beckley Psytech

The Psychedelic Mushrooms Market size is expected to reach USD 4.72 Billion in 2034 from USD 1.87 Billion (2025) growing at a CAGR of 10.81% during 2026-2034.

The Global Psychedelic Mushrooms Market is gaining attention as research into the therapeutic potential of psychedelic substances continues to expand. Psychedelic mushrooms, which contain compounds such as psilocybin, are being studied for their potential use in treating mental health conditions including depression, anxiety, and post-traumatic stress disorder. Growing interest in alternative mental health therapies is contributing to increased research and investment in this field.

Regulatory changes in several regions are also influencing market development. Some countries and states are reconsidering legal restrictions on psychedelic substances for medical research and therapeutic use. This shift is encouraging pharmaceutical companies and research institutions to explore the medical applications of psilocybin-based treatments. Additionally, clinical trials are providing new insights into the potential benefits of psychedelic-assisted therapy.

Looking forward, the Global Psychedelic Mushrooms Market is expected to evolve as scientific research continues to validate therapeutic applications. Companies are exploring pharmaceutical-grade psilocybin formulations and controlled treatment programs for mental health disorders. As awareness of mental health challenges grows and research progresses, the market for psychedelic mushroom-based therapies may experience gradual expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Form

• Processed Form
• Dried Form
• Fresh/Whole Form

By Functionality

• De-Addiction
• Anxiety Relief
• Depression Treatment
• Recreational Use

COMPANIES PROFILED

• MindMed, Atai Life Sciences, Compass Pathways, Field Trip Health, Cybin Inc, Revive Therapeutics, Numinus Wellness, Seelos Therapeutics, GH Research, Beckley Psytech
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PSYCHEDELIC MUSHROOMS MARKET: BY FORM 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Form
• 4.2. Processed Form Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Dried Form Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fresh/Whole Form Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PSYCHEDELIC MUSHROOMS MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Functionality
• 5.2. De-Addiction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Anxiety Relief Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Depression Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Recreational Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PSYCHEDELIC MUSHROOMS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Form
  • 6.2.2 By Functionality
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Form
  • 6.3.2 By Functionality
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Form
  • 6.4.2 By Functionality
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Form
  • 6.5.2 By Functionality
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Form
  • 6.6.2 By Functionality
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PSYCHEDELIC MUSHROOMS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 MindMed
  • 8.2.2 Atai Life Sciences
  • 8.2.3 Compass Pathways
  • 8.2.4 Field Trip Health
  • 8.2.5 Cybin Inc
  • 8.2.6 Revive Therapeutics
  • 8.2.7 Numinus Wellness
  • 8.2.8 Seelos Therapeutics
  • 8.2.9 GH Research
  • 8.2.10 Beckley Psytech